Get started
Author

Karen L. Lenz

Observed name: Karen Lenz
Observed institution: Becton Dickinson (United States)
ORCID: 0009-0002-0541-3448
Observed ORCID: 0009-0002-0541-3448
OpenAlex ID: A5035830185
LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade
2022 · Kyung Jin Yoo, Kellsey Johannes, et al. · The Journal of Immunology · 24
PDF
Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue
2017 · Eric P. Dixon, Lorraine M. King, et al. · Journal of Immunological Methods · 15
Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
2024 · Casey W. Shuptrine, Yuhui Chen, et al. · Cancer Research · 12
PDF
The selection and characterization of antibodies to minichromosome maintenance proteins that highlight cervical dysplasia
2011 · Dorian Henderson, Laura Hall, et al. · Journal of Immunological Methods · 10
Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test
2010 · Eric P. Dixon, Karen L. Lenz, et al. · Journal of Clinical Virology · 8
Preclinical development of SL-325, a novel high-affinity DR3-blocking antibody for durable inhibition of the DR3/TL1A axis in inflammatory bowel disease
2026 · Mahmud Hussain, Anne Y Lai, et al. · Inflammatory Bowel Diseases · 1
Abstract 1815: Rapid serial killing of target cells by Vγ9Vδ2 T Cells in cynomolgus macaques and humanized mice treated with a CD20-directed heterodimeric butyrophilin 2A1/3A1 fusion protein
2023 · Anne Y. Lai, Louis E. Gonzalez, et al. · Cancer Research · 1
Generation of Monoclonal Antibodies to the AML1-ETO Fusion Protein: Strategies for Overcoming High Homology
2011 · Stephen G. Simkins, Steven L. Knapp, et al. · Hybridoma · 1
Development and Characterization of Sl-325, a Dr3-targeted, Antagonistic Antibody for the Treatment of Ibd
2025 · Mahmud Hussain, Anne Lai, et al. · Gastroenterology
Development and Characterization of Sl-325, a Dr3-targeted, Antagonistic Antibody for the Treatment of Ibd
2025 · Mahmud Hussain, Anne Lai, et al. · Inflammatory Bowel Diseases
PDF
502 Delivery of hexameric TIGIT-Fc-LIGHT as lipid-encapsulated mRNA achieves therapeutic exposures that potentiate immune cell activation and anti-tumor activity in the setting of CPI acquired resistance
2024 · Casey W Shuptrine, Julia Satiaputra, et al. · Journal for ImmunoTherapy of Cancer
Data from Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
2024 · Casey W. Shuptrine, Yuhui Chen, et al.
Figure S1 from Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
2024 · Casey W. Shuptrine, Yuhui Chen, et al.
Figure S1 from Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
2024 · Casey W. Shuptrine, Yuhui Chen, et al.
Data from Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses
2024 · Casey W. Shuptrine, Yuhui Chen, et al.
Abstract 4214: LIGHT (TNFSF14) costimulation with TIGIT blockade broadens the activity of checkpoint inhibitors (CPIs) into CPI refractory and resistant tumors through targeted myeloid cell and effector lymphocyte activation
2022 · Kyung Jin Yoo, Louis Gonzalez, et al. · Cancer Research
Abstract #1579: Characterization of monoclonal antibodies to glycodelin showing clinical utility in the identification of ovarian cancer
2009 · Jeffrey P. Baker, Robert Cheek, et al. · Cancer Research
Works count: 17
Citation count: 72
H-index: 5
I10-index: 4
Year
Topic
Type